These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6583195)

  • 1. Safety and tolerance comparison of imipenem-cilastatin to cephalothin and cefazolin.
    Calandra GB; Ricci FM; Wang C; Brown KR
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():125-31. PubMed ID: 6583195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative clinical trial of imipenem-cilastatin (N-formimidoyl-thienamycin-dehydropeptidase inhibitor) and cefazolin.
    Marier RL; McCloskey RV; Dickenson G; Sanders CV; Aldridge KE; Hoffman T; Gutterman D; Janney A
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():133-9. PubMed ID: 6365873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal model for evaluating the convulsive liability of beta-lactam antibiotics.
    Williams PD; Bennett DB; Comereski CR
    Antimicrob Agents Chemother; 1988 May; 32(5):758-60. PubMed ID: 3395104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effects of imipenem-cilastatin on experimental intrauterine infections in rats.
    Hashizume T; Komatsu T; Okumoto Y; Ogashiwa M; Kemi M; Takase Z
    Antimicrob Agents Chemother; 1987 Apr; 31(4):578-81. PubMed ID: 3111355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, comparative trial of imipenem/cilastatin and moxalactam in the treatment of serious obstetric and gynecologic infections.
    Berkeley AS; Freedman KS; Hirsch JC; Ledger WJ
    Surg Gynecol Obstet; 1986 Mar; 162(3):204-8. PubMed ID: 3513346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
    Norrby SR; Vandercam B; Louie T; Runde V; Norberg B; Anniko M; Andrien F; Baudrihaye M; Bow E; Burman LA
    Scand J Infect Dis Suppl; 1987; 52():65-78. PubMed ID: 3331044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized study comparing clinical efficacy and safety of thienamycin formamidine (MK0787)/renal dipeptidase inhibitor (MK0791) and cefazolin.
    Ribner BS; Raeder R; Hollstein M; Freimer EH
    J Antimicrob Chemother; 1983 Oct; 12(4):387-91. PubMed ID: 6358177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipenem/cilastatin: a multicentre international study of its clinical efficacy, safety and potential as empirical therapy.
    Wang C; Pappas F; Cook T
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():185-91. PubMed ID: 3469193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imipenem/cilastatin as secondary therapy for infections in cancer patients.
    Bodey GP; Rolston K; Jones P; Alvarez ME; Fainstein V; Steelhammer L
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():161-6. PubMed ID: 3469189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of pneumonia with imipenem/cilastatin.
    Beasley CR; Humble MW; O'Donnell TV
    N Z Med J; 1985 Jun; 98(781):494-7. PubMed ID: 3859775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imipenem-cilastatin sodium, a broad-spectrum carbapenem antibiotic combination.
    Pastel DA
    Clin Pharm; 1986 Sep; 5(9):719-36. PubMed ID: 3530614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind comparison of cefazolin and cephalothin in open-heart surgery.
    Kini PM; Fernandez J; Causay RS; Lemole GM
    J Thorac Cardiovasc Surg; 1978 Oct; 76(4):506-9. PubMed ID: 359938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipenem/cilastatin in the treatment of severe hospital infections.
    Patoia L; Menichetti F; Bucaneve G; Pasticci MB; Baratta E; Grignani F; Del Favero A
    Chemioterapia; 1988 Apr; 7(2):105-8. PubMed ID: 3165056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy, safety and tolerability of intramuscular imipenem/cilastatin in the treatment of mild to moderate infections.
    Garau J; Casagrán A; Sánchez C; Matas E
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():181-3. PubMed ID: 3469192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of imipenem-cilastatin and ciprofloxacin on tests for glycosuria.
    Tartaglione TA; Flint NB
    Am J Hosp Pharm; 1985 Mar; 42(3):602-5. PubMed ID: 3157317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
    Cherif H; Björkholm M; Engervall P; Johansson P; Ljungman P; Hast R; Kalin M
    Scand J Infect Dis; 2004; 36(8):593-600. PubMed ID: 15370671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe gram-negative infections in neutropenic children cured by imipenem/cilastatin in combination with an aminoglycoside.
    Baruchel A; Hartmann O; Andremont A; Tancrède C
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():167-73. PubMed ID: 3469190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramuscular imipenem/cilastatin for treatment of mild and moderately severe bacterial infections.
    Keller CA; Villavicencio J; Ramirez C
    Scand J Infect Dis Suppl; 1987; 52():26-31. PubMed ID: 3483287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imipenem/cilastatin therapy for serious infections in neonates and infants.
    Nalin DR; Jacobsen CA
    Scand J Infect Dis Suppl; 1987; 52():46-55. PubMed ID: 3331042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of imipenem/cilastatin in patients with severe bacterial infections.
    Reutter FW
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():141-4. PubMed ID: 3469186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.